Gray

Gray Television Forms New Sports and Entertainment Revenue Group

Retrieved on: 
Friday, June 18, 2021

ATLANTA, June 18, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray) (NYSE: GTN) has formed a new sales and sponsorship entity called Gray Sports + Entertainment Sales to represent the companys internal content production portfolio to brands and advertising agencies.

Key Points: 
  • ATLANTA, June 18, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray) (NYSE: GTN) has formed a new sales and sponsorship entity called Gray Sports + Entertainment Sales to represent the companys internal content production portfolio to brands and advertising agencies.
  • Gray Sports + Entertainment Sales is led by Bill Lancaster, currently Vice President of Sales for both Raycom Sports and RTM Studios.
  • One of the great strengths of Gray Television is the passionate communities we represent through the broad array of content we produce and distribute across many different platforms said Pat LaPlatney, President and Co-CEO of Gray Television.
  • Gray Television, headquartered in Atlanta, Georgia, is the largest owner of top-rated local television stations and digital assets in the United States.

Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial

Retrieved on: 
Wednesday, June 16, 2021

Twenty-one patients with recurrent GBM have been treated in the ReSPECT trial across seven cohorts to date.

Key Points: 
  • Twenty-one patients with recurrent GBM have been treated in the ReSPECT trial across seven cohorts to date.
  • In these patients, RNL has had no dose-limiting toxicities observed with absorbed radiation doses of up to 740 Gray per tumor.
  • The eighth cohort of the ReSPECT trial will implement a 40% increase in total radioactivity.
  • Plus Therapeutics is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets.

ControlRad® Announces FDA Clearance for ControlRad Select

Retrieved on: 
Thursday, March 4, 2021

ATLANTA, March 4, 2021 /PRNewswire/ --ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select.

Key Points: 
  • ATLANTA, March 4, 2021 /PRNewswire/ --ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select.
  • In preparation for the commercialization efforts, ControlRad has entered into an exclusive agreement with Boston Scientific Corporation to sell the ControlRad Select technology.
  • "With the FDA clearance and the reach of the global medical device sales team, every cath, EP, and IR lab in the country that has a Siemens Artis zee will now have the opportunity to reduce their radiation dose by 85%1 without compromising image quality," stated Guillaume Bailliard, CEO of ControlRad.
  • ControlRad is headquartered in Atlanta, Georgia and has engineering development facilities in Kfar Saba, Israel.

GRAY NAMES STERLING SPAINHOUR TO ITS BOARD OF DIRECTORS

Retrieved on: 
Thursday, February 25, 2021

ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray, we, us or our) (NYSE: GTN) today announced that its Board of Directors unanimously voted to expand the Board by one seat and elected Sterling A. Spainhour, Jr. as an independent Director to fill that position, effective at the close of business today.

Key Points: 
  • ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray, we, us or our) (NYSE: GTN) today announced that its Board of Directors unanimously voted to expand the Board by one seat and elected Sterling A. Spainhour, Jr. as an independent Director to fill that position, effective at the close of business today.
  • Like all Directors, Mr. Spainhours term will run through our next Annual Meeting.
  • Grays Executive Chairman and CEO Hilton H. Howell, Jr., said I am thrilled to welcome Sterling to Grays Board.
  • Gray currently owns and/or operates television stations and leading digital properties in 94 television markets that collectively reach approximately 24% of U.S. television households.

GRAY TO ACQUIRE QUINCY MEDIA, INC. FOR $925 MILLION

Retrieved on: 
Monday, February 1, 2021

Interested parties should contact Wells Fargo Securities directly and should not contact Gray or Quincy about the divestiture opportunities.

Key Points: 
  • Interested parties should contact Wells Fargo Securities directly and should not contact Gray or Quincy about the divestiture opportunities.
  • In addition to the stations above, Gray will acquire Quincys Heroes & Icons affiliate WSJV in South Bend, Indiana (DMA 98) as well as WGEM(AM)/-FM in Quincy, Illinois.
  • Gray will not acquire Quincys newspaper operations, which will be divested prior to the Gray/Quincy closing.
  • Gray expects that the Quincy transaction will be immediately accretive to Grays free cash flow per share.

H2 2020 Pipeline Review on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 9, 2020

The "Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report provides an overview of the Radiation Toxicity (Toxicology) pipeline landscape.
  • The Radiation Toxicity (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects.
  • Formulate corrective measures for pipeline projects by understanding Radiation Toxicity (Toxicology) pipeline depth and focus of Indication therapeutics.

Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision

Retrieved on: 
Tuesday, December 1, 2020

A total of 15 black patients with 20 untreated keloids in various anatomic locations were recruited for the study to undergo surgical excision followed by a single dose of superficial radiation.

Key Points: 
  • A total of 15 black patients with 20 untreated keloids in various anatomic locations were recruited for the study to undergo surgical excision followed by a single dose of superficial radiation.
  • The authors concluded that a single 8 Gy dose of superficial 50 kV radiation delivered an average of 34 days after keloid excision may be sufficient to minimize recurrence, including in individuals who are resistant to steroids.
  • The authors noted that higher radiation energies, doses or fractions may be unnecessary for keloid therapy.
  • Although this was a small study, the outcome is important, said Joe Sardano, chief executive officer of Sensus Healthcare.

Worldwide Industry for Dosimeters to 2026 - Players Include Arrow Tech Biodex Medical Systems & Fluke Biomedical Among Others

Retrieved on: 
Friday, November 27, 2020

In healthcare, it is used to quantify the effective dose received by the human body from exposure to harmful ionizing radiation.

Key Points: 
  • In healthcare, it is used to quantify the effective dose received by the human body from exposure to harmful ionizing radiation.
  • Dosimeters contain phosphor crystals that capture electrons released by different sources of harmful radiation.
  • Based on technology, Optically Stimulated Luminescence (OSL) Dosimeters, Colorimetric Tubes, Thermoluminescent Dosimeters (TLDs), Electronic Dosimeters, Sorbent Tubes, and Others.
  • Some of the prominent companies are Biodex Medical Systems Inc, Arrow Tech Inc, Chp Dosimetry, Fuji Electrical Co Ltd, Fluke Biomedical, Zefon International, Gammadata Instrument Ab, Honeywell Analytics Inc, Gastech Australia, and Iba Worldwide.

Gray Files Supreme Court Brief Supporting Modernized Television Station Ownership Rules

Retrieved on: 
Tuesday, November 24, 2020

Atlanta, Georgia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray, we, or our) (NYSE: GTN) announced today that it has filed in the US Supreme Court an amicus brief supporting the reversal of a lower court decision that hinders efforts by the Federal Communication Commission (FCC) to modernize its broadcast ownership rules.

Key Points: 
  • Atlanta, Georgia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Gray Television, Inc. (Gray, we, or our) (NYSE: GTN) announced today that it has filed in the US Supreme Court an amicus brief supporting the reversal of a lower court decision that hinders efforts by the Federal Communication Commission (FCC) to modernize its broadcast ownership rules.
  • Grays brief also argues that the Third Circuits decision harms small and mid-sized communities around the nation by depriving them of the benefits of the FCCs updated broadcast ownership rules.
  • Gray anticipates a ruling by the Supreme Court by June 2021.
  • Gray currently owns and/or operates television stations and leading digital properties in 94 television markets, including the number-one rated television station in 68 markets and the first or second highest rated television station in 86 markets.

Global Dosimeter Market (2020 to 2026) - by Technology, End-user, Device and Geography - ResearchAndMarkets.com

Retrieved on: 
Friday, November 20, 2020

The "Dosimeter Market by Technology Dosimeters, Colorimetric Tubes, Thermoluminescent Dosimeters, Sorbent Tubes, and Others), End-user, Device and Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dosimeter Market by Technology Dosimeters, Colorimetric Tubes, Thermoluminescent Dosimeters, Sorbent Tubes, and Others), End-user, Device and Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Dosimeters are analytical instruments used to measure the amount of energy released by ionizing radiation.
  • In healthcare, it is used to quantify the effective dose received by the human body from exposure to harmful ionizing radiation.
  • In addition, the rising number of nuclear power plants is providing the scope for market growth.